The Effect Hypnosis On Acute Myeloid leukemia
- Conditions
- acute myeloid.Acute myeloblastic leukaemia, minimal differentiation Acute myeloblastic leukaemia (with maturation) AML1/ETO AML M0 AML M1 AML M2 AML with t(821) AML (without a FAB classification) NOS Refractory anaemia with excess blasts in transformation Excl.: acute
- Registration Number
- IRCT2015010314928N2
- Lead Sponsor
- Islamic Azad University Sari Branch
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 86
The age group between 18 and 50 years- completed consent form to participate in the plan- absence of severe depression with- absence seizures are not controlled- absence of anti social character- psychosis had no- medical record at the clinic of Imam Khomeini hospital- gardener and get diagnosed acute myeloid leukemia by flow cytometry test
Exclusion criteria: Each treatment when the patient can be removed from the plan.- The experimental group hypnosis therapy done by indoctrinating during six 40-minute sessions- control group received hypnosis therapy- gardeners with no medical record at the clinic and Imam Khomeini hospital in Sari city- with no testing of flow cytometry for the detection of acute myeloid leukemia
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: Before Intervention In The First Session And After The last Intervention At An Interval Of 3 Months In The last Session. Method of measurement: Inventory McGill Pain Management.;Anxiety Death. Timepoint: Before Intervention In The First Session And After The last Intervention At An Interval Of 3 Months In The last Session. Method of measurement: Questionnaires Collett-Lester Anxiety Death.;Resiliency. Timepoint: Before Intervention In The First Session And After The last Intervention At An Interval Of 3 Months In The last Session. Method of measurement: Questionnaires Resilience Cooner And Davidson.;Cure Of Cancer Cells. Timepoint: Before Intervention In The First Session And After The last Intervention At An Interval Of 3 Months In The last Session. Method of measurement: Flow Cytometry Tests To Measure CD4 And CD8 Markers Aand Measuring The Ratio Of CD4 To CD8 lymphocyte Percentage ,easurements.
- Secondary Outcome Measures
Name Time Method